Hyp entheses have enhanced BMP and IHH signaling and ALP activity by P14, which is prevented if increasing 1,25D action with 1,25D or FGF23Ab therapy is initiated by P2 (prior to development of enthesis changes), suggesting XLH enthesopathy develops in the early postnatal period (14). The gene discussed is IHH; the disease is enthesopathy.